Robot-Assisted vs. Video-Assisted Lobectomy for NSCLC (RAVAR)

Study acronym: RAVAR
StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing Show 4 more changesShow less
    • Eligibility criteria shortened, about 23 words
    • Secondary endpoints: details revised at 3 of 15 entries
    • Site details revised at 23 of 23 sites
    • Collaborators: details revised at 6 of 22 entries
  2. Primary completion date: Dec 31, 2025 to Dec 31, 2030
    • Study sites: 24 to 23
    • Start date: Aug 26, 2020 to Aug 25, 2020
    • Collaborators: 23 to 22
    v3
  3. Primary completion date: Dec 31, 2024 to Dec 31, 2025
    • Study sites: 21 to 24
    • Study completion date: Dec 31, 2029 to Dec 31, 2030
    • Collaborators: 20 to 23
    v2
  4. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Video-assisted thoracic surgery (VATS) has been recommended by clinical guidelines as one of the preferred surgeries for early-stage non-small cell lung cancer (NSCLC) for many years. However, VATS has inherent drawbacks, so at the beginning of this century, robotic-assisted thoracoscopic surgery (RATS) was first applied for lung resection. In recent years, RATS has developed rapidly, but there are still many unsolved scientific problems in the field of RATS. Thus, a multicenter prospective randomized controlled trial was conducted with stage I-II NSCLC patients as the study subject and 5-year DFS as the primary endpoint to compare the short-term and long-term outcomes of RATS and VATS in the treatment of early-stage NSCLC.
Trial Details
NCT Number NCT06524427
Lead Sponsor Sun Yat-sen University
Collaborators: The First Affiliated Hospital of Nanchang University, The Affiliated Hospital of Qingdao University, The General Hospital of Eastern Theater Command, Gansu Provincial Hospital, Tang-Du Hospital, Wuhan TongJi Hospital, First Affiliated Hospital of Chongqing Medical University, West China Hospital, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Shenzhen People's Hospital, The First Affiliated Hospital of Zhengzhou University, Shandong Provincial Hospital, Jiangsu Cancer Institute & Hospital, Guangdong Provincial People's Hospital, Liaoning Cancer Hospital & Institute, Qilu Hospital of Shandong University, Jiangxi Provincial People's Hopital, Sichuan Cancer Hospital and Research Institute, Lanzhou University Second Hospital, Shenzhen Third People's Hospital, Qianfoshan Hospital, Guangxi Nanxishan Hospital
Conditions
(from sponsor)		 Non Small Cell Lung Cancer
Related terms Carcinoma, Non-Small-Cell Lung
Enrollment 1,124 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov